ישראל -
עברית -
Ministry of Health
קרדיוקסאן
megapharm ltd - dexrazoxane as hydrochloride - אבקה להכנת תמיסה לאינפוזיה - dexrazoxane as hydrochloride 500 mg/vial - dexrazoxane - dexrazoxane - prevention of cardiotoxicity in adult women with advanced and/or metastatic breast cancer at high risk of heart failure who have received a prior cumulative dose of 300 mg/m2 of doxorubicin or a prior cumulative dose of 540 mg/m2 of epirubicin when further anthracycline treatment is required.